Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies : Journal of Clinical Neuromuscular Disease

Secondary Logo

Journal Logo

Original Article

Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies

Zeidman, Lawrence A. MD, FAAN*,†; Kubicki, Konrad MA

Author Information
Journal of Clinical Neuromuscular Disease 22(4):p 192-199, June 2021. | DOI: 10.1097/CND.0000000000000355

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid